Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 14 Polycystic Ovary Syndrome 9 Neoplasms 5 Endometrial Neoplasms 3 Prostatic Neoplasms 2 Peripheral Nervous System Diseases 2 Obesity 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Melanoma 2 Leukemia, Myeloid, Acute 2 Leiomyoma 2 Insulin Resistance 2 Inflammation 2 Infertility, Female 2 Glioblastoma 2 Diabetes Mellitus 2 Colorectal Neoplasms 2 Cognitive Dysfunction 2 Cardiotoxicity 2 Weight Gain 1 Vomiting 1 Venous Thromboembolism 1 Vascular Malformations 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Stem Cell Transplant Complications 1

Interventions

bismuth tripotassium dicitrate 1 Tetracycline 1 Tablets 1 Observation 1 Metronidazole 1 Lacteol 1 Esomeprazole 1 Colonoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Dysbiosis × Tablets × Clear all

NCT04527055 2024-06-24

Bsm10

National Cheng-Kung University Hospital

Phase 4 Enrolling by invitation

Dysbiosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡